ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OBD Oxford Biodynamics Plc

0.63
-0.02 (-3.08%)
30 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biodynamics Plc LSE:OBD London Ordinary Share GB00BD5H8572 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.02 -3.08% 0.63 0.60 0.70 0.65 0.65 0.65 2,627,564 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 1.34M -10.83M -0.0347 -0.19 2.03M
Oxford Biodynamics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker OBD. The last closing price for Oxford Biodynamics was 0.65p. Over the last year, Oxford Biodynamics shares have traded in a share price range of 0.50p to 16.05p.

Oxford Biodynamics currently has 311,860,000 shares in issue. The market capitalisation of Oxford Biodynamics is £2.03 million. Oxford Biodynamics has a price to earnings ratio (PE ratio) of -0.19.

Oxford Biodynamics Share Discussion Threads

Showing 2026 to 2040 of 2050 messages
Chat Pages: 82  81  80  79  78  77  76  75  74  73  72  71  Older
DateSubjectAuthorDiscuss
23/1/2025
07:55
Where’s that fool boysie 72 🤡📉🕳️€169;
ny boy
14/1/2025
22:42
How did Iain Ross's turnaround at RENE go

Soiled his record (so far)

thiopia
14/1/2025
17:48
6m won't cut it I'm afraid redundancies etc would decimate that . They are too far gone at this stage and without immediate huge cuts will just end up begging for cash again . Break even os a very long way off will take years even at reduced cost base
bones698
14/1/2025
17:34
They've got a turnaround specialist on board (Iain Ross) with a remit to stabilise the company and get it onto a breakeven basis.
jaknife
14/1/2025
17:22
Lmao so 0.5p or bust . Won't last them long unfortunately and will be back in the same situation with no willing buyers and noncash left . Just prolonging the inevitable here I'm afraid
bones698
14/1/2025
14:16
Looks like will end up in admin . Poor management no cost controls just blew the money
bones698
24/12/2024
09:44
You would have thought that on Christmas Eve of all days, the directors of OBD might have said, instead of allotting themselves yet more shares in lieu of salary, “Having presided over a 90% share price fall since the last placing less than a year ago which was carried out using wildly over optimistic assumptions, the directors on this occasion are waiving their entitlement to shares in lieu of salary as a seasonal gesture to our long suffering shareholders”.

Happy Christmas!!

bowerdean
19/12/2024
15:04
Thebd11 totally agree they will try all avenues but it will come back to fund raise to keep going . The problem here is they never cut costs and kept blowing cash for fun . For me the tech may be good but the management have destroyed any chance of it's success . Will send up in admin and someone else likely but the IP and use it to much better effect

Eve if they raise 5m at 0.2p it won't last 6 months that is getting problem here ,they won't be able to raise much more given the mkt cap either . It's already to late for investors imo

bones698
19/12/2024
09:34
My guess is this will raise at sub 0.2p, maybe 0.1. Current equity holders wiped out unfortunately, new management shuts this thing down except for US sales team promoting the prostate testing. 2 years cash raised, take a run at the PSE, minimise expenses. Would imagine they'll explore sale of almost any other asset, but this will take some time and in an immediate case will need to shut down expenditure related to developing any other tests. I'll maybe meet with Ian in the new year and see whether this is the case, but it doesn't look good for the existing equity that's for sure, sadly.
thebd11
16/12/2024
17:34
Matthew Wakefield, Chairman of Oxford BioDynamics said: "On behalf of the Board, I would like to thank Jon for his contribution to the Company over the last four years. In that time, Jon has led the Company from being predominantly R&D focused to a position where we now have two tests on the market"

That sounds better than he's led the share price from £1 four years ago to 1p now!

elpirata
16/12/2024
08:20
Yep will get forward sold and drop to around 0?5p then a discount for the placing so anything from 0.2p possible here now . No upside at all
bones698
16/12/2024
08:06
Will get walked down in coming weeks as the placing gets arranged at a much lower price . Holders getting wiped out . Should have listened
bones698
16/12/2024
07:03
Will get slaughtered today as equity fund raise will be around 0.2-0.5p . There simply is no money for these type of companies other then equity raises which is highly dillutive .
bones698
04/12/2024
08:33
Yup it's suckered in a load yesterday and they will.makena loss today suckers
bones698
08/11/2024
14:28
Bones is a bellwether to do the exact opposite . He seems to go round all advfn being a complete bellend
moontheloon
Chat Pages: 82  81  80  79  78  77  76  75  74  73  72  71  Older